Skip to main content
. Author manuscript; available in PMC: 2011 May 16.
Published in final edited form as: Psychopharmacology (Berl). 2007 Mar 29;193(2):159–170. doi: 10.1007/s00213-007-0766-3

Table 3.

Effects of the D2 antagonist L-741,626 and the D3 antagonist U99194 on D2/D3 agonist-induced hypothermiaa

Vehicle 1.0 L-741,626 3.2 U99194
Agonist Δ Temp. (±SEM) Δ Temp. (±SEM) Δ Temp. (±SEM)
Pramipexole – 0.32 mg/kg −1.50 (±0.11) **−0.52 (±0.13) −1.51 (±0.06)
PD-128,907 – 0.32 mg/kg −1.30 (±0.12) **−0.38 (±0.12) −1.34 (±0.17)
7-OH-DPAT – 0.1 mg/kg −1.15 (±0.23) **−0.53 (±0.10) −1.12 (±0.17)
Quinpirole – 0.1 mg/kg −0.93 (±0.14) *−0.23 (±0.15) −0.84 (±0.22)
Quinelorane – 0.01 mg/kg −0.73 (±0.07) *−0.52 (±0.05) −0.67 (±0.05)
U91356A – 0.32 mg/kg −1.25 (±0.17) **−0.58 (±0.12) −1.29 (±0.18)
Apomorphine – 0.1 mg/kg −0.74 (±0.13) *−0.39 (±0.07) −0.72 (±0.08)
Sumanirole – 1.0 mg/kg −1.05 (±0.10) *−0.50 (±0.07) −1.09 (±0.13)

5-HT1A-preferring
8-OH-DPAT – 1.0 mg/kg −2.61 (±0.08) −2.73 (±0.08) −2.56 (±0.09)
a

Antagonists were administered as 30 min pretreatments with Δ Temp. representing the change in core body temperature 30 min after, compared to 1 min prior agonist administration. Data are expressed as mean ±SEM, n=8 rats per group;

*

p<0.05,

**

p<0.01 with respect to Δ Temp of antagonist treated rats compared to vehicle treated rats.